• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Aehr Test Systems (AEHR) Swung To Profit, Is 51% Undervalued?

    Simply Wall St·11/10/2026 10:19:22
    Listen to the news

    Aehr Test Systems (AEHR) drew fresh attention after reporting first quarter results on November 2, 2026, with sales of US$33.01 million and net income of US$7.18 million from continuing operations.

    Aehr Test Systems’ share price has reacted sharply to the earnings release, with an 11.65% 1 day share price return and 16.20% over the past week, even though the 30 day and 90 day share price returns are down 29.34% and 48.96% respectively.

    Scan other semiconductor players that may benefit from similar demand trends with our curated list of 53 AI infrastructure stocks.

    Aehr Test Systems just turned a prior quarter loss into a profit and the share price has swung sharply in response. The real tension now is whether that improving story is already fully baked into today’s valuation.

    Most Popular Narrative: 50.6% Undervalued

    Aehr Test Systems closed at $59.81, while the analyst consensus Narrative on Simply Wall St assigns a fair value of $121.00. This frames the recent swing as a debate about how quickly AI driven demand can translate into sustained earnings power.

    Rising AI processor and data center demand is feeding into Aehr Test Systems' FOX wafer-level and Sonoma package-level platforms. These platforms are tied to large purchase orders, a record backlog of about US$100.6 million, and a fiscal 2027 revenue outlook of US$130 million to US$150 million that directly targets higher revenue and operating income.

    See why 8 investors see Aehr Test Systems as 51% undervalued.

    Result: Fair Value of $121.00 (UNDERVALUED)

    Still, the story around Aehr Test Systems could change quickly if AI and data center customers slow capital spending, or if a major concentrated customer pulls back.

    Find out about the key risks to this Aehr Test Systems narrative.

    Another View On Aehr Test Systems: Rich Multiples, Different Message

    While the analyst Narrative and DCF style fair value work point to Aehr Test Systems as 50.6% undervalued, the simple P/S check tells a very different story. AEHR trades on a P/S of 39.2x compared with 5.7x for the US Semiconductor group and 2.6x for close peers, while the fair ratio is 5.4x. That gap leaves far less room for error if growth or margins land closer to the middle of the range than the bullish end.

    For a deeper look at what this pricing gap could mean in practice, including how far the multiple might drift toward the fair ratio if sentiment cools, See what the numbers say about this price — find out in our valuation breakdown..

    NasdaqCM:AEHR P/S Ratio as at Nov 2026
    NasdaqCM:AEHR P/S Ratio as at Nov 2026

    Next Steps

    If the split between enthusiasm and caution around Aehr Test Systems feels sharp, treat that as your cue to move fast and interrogate the evidence yourself. To weigh both sides of the story in one place, start with the 3 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Aehr Test Systems?

    Do not stop your research with Aehr Test Systems alone. Broader opportunity often shows up where fewer investors are looking, and that is where edges can emerge.